Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

Acute stroke device: mixed results

You may also be interested in...

New Products In Brief

Abbott earns approval in Japan for Xience Xpedition everolimus-eluting stent. Zimmer will distribute SpineCraft’s APEX system. More new product news.

Research In Brief

Data preview for Heart Rhythm Society conference in Denver this week. More research news.

Research In Brief

SynCardia heart portable driver: Company has received conditional IDE approval to begin a study of its Freedom portable driver to power the CardioWest total artificial heart in bridge-to-cardiac-transplant patients. The trial, which will enroll 60 subjects, aims to demonstrate that stable CardioWest patients can manage their portable driver outside the hospital. According to SynCardia, a "major drawback" of existing technology is that patients are attached to a 418-pound driver and confined to the hospital while they await transplant. By contrast, the Freedom driver weighs 13.5 pounds and would enable patients to resume normal activities while awaiting a transplant, the firm says. The study will follow patients until transplant, 90 days after discharge, 90 days of Freedom support in the hospital or death. The Freedom driver received CE mark approval for use in Europe March 1


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts